Not logged in...
About USC Norris
FAQ - Trials
Contact Us - Trials
Support USC Norris
» Contact Us
If you are a patient, please contact
Keck Medical Center of USC
A Phase I Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics and Safety of Crizotinib in Advanced Cancer Patients.
Open to Accrual
Defintions of terms and FAQ about clinical trials.
Anthony El-Khoueiry, M.D.
Other Trial Staff:
Xiomara Menendez, R.N., Arthur Alvarez, D.M., Jubilee Acap, Coordinator, Arthur Alvarez, D.M., Khatchik Karakozian, D.M., Molly Oswald, R.N., Sherine Elsayegh, Coordinator
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.